Growing community of inventors

Groton, CT, United States of America

Vincent Mascitti

Average Co-Inventor Count = 1.73

ph-index = 6

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 70

Vincent MascittiJennifer A Doudna (1 patent)Vincent MascittiMichael John Munchhof (53 patents)Vincent MascittiKentaro Futatsugi (29 patents)Vincent MascittiSpiros Liras (6 patents)Vincent MascittiMichael P Deninno (13 patents)Vincent MascittiBenjamin A Thuma (6 patents)Vincent MascittiDaniel Wei-Shung Kung (11 patents)Vincent MascittiRomain Rouet (1 patent)Vincent MascittiBenjamin M Collman (1 patent)Vincent MascittiBenjamin Thuma (0 patent)Vincent MascittiRalph Pelton Robinson (0 patent)Vincent MascittiKim Francis Mcclure (0 patent)Vincent MascittiBruce Allen Lefker (0 patent)Vincent MascittiBenjamin Micah Collman (0 patent)Vincent MascittiVincent Mascitti (11 patents)Jennifer A DoudnaJennifer A Doudna (138 patents)Michael John MunchhofMichael John Munchhof (53 patents)Kentaro FutatsugiKentaro Futatsugi (29 patents)Spiros LirasSpiros Liras (18 patents)Michael P DeninnoMichael P Deninno (13 patents)Benjamin A ThumaBenjamin A Thuma (12 patents)Daniel Wei-Shung KungDaniel Wei-Shung Kung (11 patents)Romain RouetRomain Rouet (1 patent)Benjamin M CollmanBenjamin M Collman (1 patent)Benjamin ThumaBenjamin Thuma (0 patent)Ralph Pelton RobinsonRalph Pelton Robinson (0 patent)Kim Francis McclureKim Francis Mcclure (0 patent)Bruce Allen LefkerBruce Allen Lefker (0 patent)Benjamin Micah CollmanBenjamin Micah Collman (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Pfizer Corporation (11 from 4,455 patents)

2. University of California (1 from 15,462 patents)


11 patents:

1. 10851367 - Tissue-specific genome engineering using CRISPR-Cas9

2. 10813942 - Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR

3. 10376531 - Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR

4. 10039778 - Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR

5. 9617293 - Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR

6. 9439901 - Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives

7. 9439902 - Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives

8. 9340553 - Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR

9. 9308204 - Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives

10. 8669380 - Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives

11. 8080580 - Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/9/2025
Loading…